Biovail named to the Toronto Stock Exchange (TSE) 300 Composite Index; Listing to Commence January 15, 1996.TORONTO, Canada--(BUSINESS WIRE)--Jan. 12, 1996--Biovail Corporation International (AMEX AMEX See: American Stock Exchange , TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). :BVF BVF Biovail Corporation (stock symbol) BVF Berufsverband der Frauenärzte eV (Muenchen, Germany) BVF Bearing Versus Frequency ) today announced it has received notification that it will be added to the TSE 300 Composite Index Composite Index A grouping of equities, indexes or other factors combined in a standardized way, providing a useful statistical measure of overall market or sector performance over time. Also known simply as a "composite". within the subgroup 5.8 - Biotechnology/Pharmaceuticals, effective before the market's open on Monday, January 15, 1996. Biovail will also be added to the TSE 200 Index at the same time. Biovail Corporation International is an international full-service pharmaceutical company, engaged in the formulation, clinical evaluation, registration and manufacture of drug products utilizing advanced drug delivery technologies. CONTACT: Biovail Corporation International, Toronto Eugene Melnyk, (416) 285-6000 or Morgen-Walke Associates, New York Investor Relations: Donna Stein/Courtney Levi/ Cindy Hintelmann Press: Stacy Berns (212) 850-5600 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion